DrugsControl Media Services

News Detail

2 Pharma companies restrained from making diabetes drug (04-02-2023)

AHMEDABAD, 4 FEB 2023: Two local pharmaceutical companies have been restrained from manufacturing and marketing a drug for Type 2 diabetes after a German pharma giant claimed they had infringed on its patent rights. 

The case involves Germany's Boehringer Ingel......
View Details

Source : The Times of India
linagliptin boehringer west coast pharmaceutical works ltd aashish malhotra health news

Related News